Invention Grant
US08173643B2 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof
有权
N-取代的硫代吗啉衍生物作为二肽基肽酶IV的抑制剂及其药物用途
- Patent Title: N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof
- Patent Title (中): N-取代的硫代吗啉衍生物作为二肽基肽酶IV的抑制剂及其药物用途
-
Application No.: US12593717Application Date: 2007-06-01
-
Publication No.: US08173643B2Publication Date: 2012-05-08
- Inventor: Song Li , Wu Zhong , Junhai Xiao , Xinghai Ma , Lili Wang , Hongying Liu , Zhibing Zheng
- Applicant: Song Li , Wu Zhong , Junhai Xiao , Xinghai Ma , Lili Wang , Hongying Liu , Zhibing Zheng
- Applicant Address: CN Beijing
- Assignee: Beijing Molecule Science and Technology Co., Ltd.
- Current Assignee: Beijing Molecule Science and Technology Co., Ltd.
- Current Assignee Address: CN Beijing
- Agency: MacMillan, Sobanski & Todd, LLC
- Priority: CN200710090694 20070403
- International Application: PCT/CN2007/001757 WO 20070601
- International Announcement: WO2008/119208 WO 20081009
- Main IPC: C07D295/185
- IPC: C07D295/185 ; A61K31/54

Abstract:
The present invention relates to N-Substituted thiomorpholine compounds of formula I, the possible isomers, the pharmaceutically acceptable salts, the solvates, the hydrates or the prodrugs thereof as inhibitors of dipeptidyl peptidase IV (DPP-IV); and to a method for preparing the compounds of formula I, pharmaceutical compositions comprising the compounds of formula I and use of the compounds of formula II in medical field, particularly in the preparation of medicaments for treating and preventing diabetes (in particular type II diabetes), hyperglycemia, X syndrome, hyperinsulinemia, obesity, atherosclerosis and all kinds of diseases modulated by immune system.
Public/Granted literature
Information query